Back to search
FDAFDA · Food and drugs·Recall number D-0028-2025

Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India., NDC 43598-369-30.

Published November 6, 2024 · Recall initiated: October 9, 2024

Summary

FDA records drug Class II recall D-0028-2025, published November 6, 2024 and initiated October 9, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 10584 bottles; Lot: Lot# T2201443, Exp 03/2025; T2300664, Exp 12/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

What to do

Voluntary: Firm initiated · Letter

Get an email if CINACALCET has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CINACALCET
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA Nationwide.
UPC
0343598369303
Lot
Lot# T2201443, Exp 03/2025; T2300664, Exp 12/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India., NDC 43598-369-30. recalled?

Yes. FDA published recall D-0028-2025 on November 6, 2024. Reported hazard: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CINACALCET. UPC: 0343598369303.